DexCom director Mark G. Foletta disposes of 4,000 common shares worth $330,640
DXCM•Director reports share sales through a trust
DexCom director Mark G. Foletta reported sales of 4,000 common shares at USD 80 to USD 85.32 per share.
The transactions occurred on July 31, 2026 and Aug. 3, 2026 through a trust.
Beneficial ownership held by the trust fell to 48,852 shares following the sales.
